2005 Annual Meeting | Movement Disorders

Date Friday 04/15/05

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) Kathleen M. Shannon, MD, FAAN

Topic(s) Movement Disorders

Learning Objectives Upon completion:
Participants should be familiar with relationships between genes, proteins and phenotype in parkinsonism, chorea, dystonia and ataxia; be aware of refined and novel pharmacological approaches to Parkinson's disease; understand practical management of dystonia, ataxia, and behavioral manifestations of movement disorders; and recognize the promise and potential pitfalls of gene therapy in Parkinson's disease and Huntington's disease.

The American Board of Psychiatry and Neurology has reviewed Movement Disorders and has approved this product as part of a comprehensive lifelong learning program, which is mandated by the ABMS as a necessary component of maintenance of certification.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
09:00 AM - 09:45 AM		From Protein to Phenotype: Clinicopathological Studies in Parkinsonism Irene Litvan, MD, FAAN
09:45 AM - 10:30 AM		Motor Disability in Parkinson's Disease: Dopamine and Beyond Robert A. Hauser, MD, MBA, FAAN
10:30 AM - 10:45 AM		Break
10:45 AM - 11:30 AM		Chorea: Phenotype and Genotype Ruth H. Walker, PhD, MB, ChB
11:30 AM - 12:15 PM		Practical Approach to Dystonia Steven Frucht, MD
12:15 PM - 01:30 PM		Lunch
01:30 PM - 02:15 PM		Navigating Ataxia: Recognition, Diagnosis, and Management Jennifer G. Goldman, MD, MS, FAAN
02:15 PM - 03:00 PM		Recognition and Management of Psychiatric Disturbances in Movement Disorders Irene Richard, MD, FAAN
03:00 PM - 03:15 PM		Break
03:15 PM - 04:15 PM		Prospects for Gene Therapy in Parkinson's Disease and Huntington's Disease Jeffrey Kordower, PhD
04:15 PM - 05:00 PM		Fun and Unusual Cases in Movement Disorders Kathleen M. Shannon, MD, FAAN

Faculty Disclosures
Steven Frucht, MD	Dr. Frucht has nothing to disclose.
Kathleen M. Shannon, MD, FAAN	The institution of Dr. Shannon has received research support from Inhibikase Therapeutics. The institution of Dr. Shannon has received research support from ASKBIO. Dr. Shannon has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH.
Irene Litvan, MD, FAAN	Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aprinoia. Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Litvan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. Dr. Litvan has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Editor with Frontiers in Neurology.
Robert A. Hauser, MD, MBA, FAAN	Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDerm. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance Therapeutics. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Supernus Pharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regenxbio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Forsee Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KiefeRx. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Truebinding. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serina Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nano PharmaSolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorridi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Conterra Pharma. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Theravance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Photopharmics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NDP Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has stock in Inhibikase. Dr. Hauser has stock in Axial Therapeutics. Dr. Hauser has stock in Enterin. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Ruth H. Walker, PhD, MB, ChB	Dr. Walker has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc, Inc.. The institution of Dr. Walker has received research support from Department of Veterans Affairs.
Jennifer G. Goldman, MD, MS, FAAN	Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation Scientific Advisory Board. The institution of Dr. Goldman has received research support from Michael J. Fox Foundation. The institution of Dr. Goldman has received research support from Parkinson's Foundation.
Irene Richard, MD, FAAN	Dr. Richard has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Katten Muchin Rosenman Law Firm. The institution of Dr. Richard has received research support from Michael J Fox Foundation for Parkinson's Research.
Jeffrey Kordower, PhD	No disclosure on file

��ɫ��

��ɫ��